---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-25-000056"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2025-04-22T23:59:59+00:00"
generated_at: "2026-05-23T09:01:04.784926+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q1 2025 revenue $48.8B (+15.4% YoY); adj. diluted EPS $11.97; reaffirms FY guidance

## Summary
- Operating revenue $48.8B (+15.4% YoY); diluted GAAP EPS $9.61, adjusted diluted EPS $11.97.
- Benefit expense ratio 86.4% (+80 bps YoY); operating expense ratio 10.9% (-70 bps).
- Health Benefits segment op. revenue $41.4B, op. gain $2.2B; Carelon op. revenue $16.7B, op. gain $1.1B.
- Medical membership ~45.8M (+99K from year-end); returned $1.3B capital via buybacks & dividends.
- Reaffirmed FY 2025 adjusted diluted EPS guidance $34.15-$34.85; Q2 dividend $1.71/share declared.

## SEC filing metadata
- accession: 0001156039-25-000056
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2025-04-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/0001156039-25-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/elv-20250422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-25-000056
- JSON: https://secwatch.observer/filing/0001156039-25-000056.json
- Plain text: https://secwatch.observer/filing/0001156039-25-000056.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.